Pound P.
‘Breaking the lock-in to animal research within academia’. 11th World Congress on Alternatives and Animal Use in the Life Sciences, 2 September 2021.
Presentation
Ram R.
‘New Approach Methodologies Funding and Regulation’. 11th World Congress on Alternatives and Animal Use in the Life Sciences, 30 August 2021.
Presentation
Turner J.
‘Overcoming data availability obstacles in the way of evidence-based toxicology’. EBTC Scientific Symposium #4, 14 July 2021
Slides
Turner J.
‘Developing Methods and Technologies to Ensure Safe and Effective Medicines’. Westminster Health Forum meeting, 1 April 2021
Presentation.
Turner J.
‘Developing Methods and Technologies to Ensure Safe and Effective Medicines’. Westminster Health Forum meeting, 7 August 2020
Presentation.
Kenna, G.
‘Human-relevant models are needed to understand and treat human COVID-19 disease’. PCRM’s Congressional hearing “Confronting COVID-19: A Briefing on Prioritizing Human-Based Research, 7 July 2020
Presentation
Pound P.
Invited keynote lecture: ‘Are researchers moving away from animal models as a result of poor translation in the field of stroke? An analysis of opinion papers’. Symposium ‘After Translational Strategies’, Utrecht University, Utrecht, Netherlands, 27 November 2019.
presentation for symposium
Pound P, Ram R.
Are researchers moving away from animal models as a result of poor translation in the field of stroke? European Society for Alternatives to Animal Testing (EUSAAT) Congress, Linz, Austria, 10-13 October 2019.
analysis of opinion papers in stroke Pandora Pound
Kenna, G.
Overcoming obstacles to human-relevant science. WIST 2nd Congress: Science instead of animals. Cologne, Germany, October 27, 2018
Kenna, G.
Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2018. Cambridge, UK. July 23, 2018
ACT_Kenna_2018
Kenna, G.
Pharmacokinetics and ADME. ACT Course on Practical Application of Toxicology in Drug Development, 2017. Cambridge, UK. July 19, 2017
Kenna, G.
Integrating DILI Hazards to Predict Toxicity of Drug Candidates. Assessment and Management of Human Risk in the Pharmaceutical Industry. 21
st North American ISSX Meeting. Rhode Island, USA. September 24, 2017
ISSX21_Kenna_2017
Kenna, G.
How non-animal approaches can aid the design and selection of safe drugs. Applied Toxicology Modular MSc Course. Guildford UK. November 11, 2017
Surrey_Kenna_2017
Kenna, G.
BSEP inhibition and Drug Induced Liver Injury. SOLVO ‘Meet the Experts: The Transporter Conference. Budapest, Hungary. May 12, 2016
SOLVO_GK slides_09052016
Kenna, G.
Drug induced Liver Injury (DILI): What is the Problem? 11th International ISSX Meeting. Busan, South Korea. June 12, 2016
ISSX_2016_KennaDILI_1
Kenna, G.
Integrating DILI hazards enables prediction, assessment and management of human risk. 11th International ISSX Meeting. Busan, South Korea, June 12, 2016
ISSX_2016_KennaDILI_2
Kenna, G.
Pharmacokinetics and ADME ACT Course on Practical Application of Toxicology in Drug Development, 2016. Cambridge, UK. July 13, 2016
ACT_2016_GK slides_18052016
Kenna, G.
Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Recommendations to the regulatory agencies concerning BSEP screening in drug discovery and development. PSTC global webinar. July 14, 2016
BSEP_Webinar_Kenna_2016
Kenna, G.
Regulating Chemical Safety – the future for animal use. How understanding drug toxicities can aid human chemical safety assessment without using animals. The Lush Prize Conference 2016. London, UK. November 10, 2016
Lush_2016_Kenna
Kenna, G.
Integrating data from multiple in vitro methods enable prediction of serious human adverse drug reactions. World Preclinical Congress Europe. Lisbon, Portugal. November 16, 2016
WPC_GK_28102016
